Xylem
- Market cap
- 23.77B
- P/E (TTM)i
- 24.24
- P/Bi
- 2.28
- EPSi
- 3.92
- Div yieldi
- 1.63%
- 52W posi
- 6%
Anonymous reader poll. Unscientific, not investment advice.
Xylem last traded at 101.82, down 2.63% on the session. That leaves the company valued at approximately 23.77B, the #827 most valuable US-listed company we track. The trailing P/E of 24.11 is 42% below its five-year average of 41.67. Income-focused holders are looking at a trailing yield of 1.63% here. Wall Street's 14-analyst consensus lands on Buy, with a price target averaging 152.33 (+50% from here). Against a 52-week band of 98.58-152.14, the shares are currently 6% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 2 months.
- Its last 4 Sell calls were actually followed by a +4% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -22.8% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 4.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 24.4x | Better than 37% |
| Forward P/E | 19.8x | Better than 42% |
| Price / Sales | 2.6x | Better than 55% |
| P/E vs own 5-yr range | 0th pctl | Better than 98% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 17.8% | Better than 81% |
| Net income CAGR (3Y) | 39.2% | Better than 88% |
| Free cash flow CAGR (3Y) | 32.9% | Better than 79% |
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 38.5% | Better than 43% |
| Operating margin | 14.7% | Better than 49% |
| Net margin | 10.6% | Better than 48% |
| Return on equity | 8.7% | Better than 32% |
| Return on invested capital | 7.3% | Better than 41% |
Momentum D
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -14.8% | Better than 18% |
| 6-month return | -16.9% | Better than 14% |
| 12-month return (ex latest month) | -28.5% | Better than 8% |
| Distance below 52-week high | 32.7% | Better than 23% |
Financial Health B+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.6x | Better than 57% |
| Debt to assets | 11.7% | Better than 75% |
| Interest coverage | 41.7x | Better than 87% |
| Free cash flow / net income | 95.1% | Better than 36% |
Analyst View B+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 64.3% | Better than 39% |
| Upside to average target | 48.7% | Better than 82% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 104.57
- Open
- 103.39
- Day range
- 101.62 - 103.80
- Avg price
- 102.25
- Volume
- 2.48M
- Turnover
- 253.37M
- Turnover ratei
- 1.06%
- Volume ratioi
- 0.90
- Amplitudei
- 2.09%
- 52-week rangei
- 98.58 - 152.14
Valuation
- P/Ei
- 25.97
- P/E (TTM)i
- 24.24
- P/Bi
- 2.28
- EPSi
- 3.92
- Book value / shi
- 44.63
- Net profit
- 915.27M
- Net assets
- 10.42B
Share structure
- Market cap
- 23.77B
- Float capi
- 23.71B
- Shares out
- 233.49M
- Float sharesi
- 232.88M
Dividend & listing
- Div yield (TTM)i
- 1.63%
- Dividend (TTM)
- 1.66
- Listing date
- 1970-01-01
33.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-72.86M net over the window
Short interest
- Shares short
- 10.90M
- % of floati
- 4.67%
- Days to coveri
- 3.76
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Xylem (XYL)?
Xylem last traded at 101.82. The quote on this page refreshes every few seconds while US markets are open.
What is Xylem's market cap?
About 23.77B.
What is the P/E ratio of Xylem?
The trailing twelve-month P/E is 24.24, below its own 5-year average of 41.67 — toward the bottom of its historical range (0.24% percentile). See the Valuation tab for the full history.
Does Xylem pay a dividend?
Yes. The trailing dividend yield is 1.63%. The 2025 payout was up 11.1% from 2024. See the Dividends tab for the full payment history.
Is Xylem a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 152.33, which implies 49.6% upside from the current price. This is not investment advice.
What is Xylem's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Xylem a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-10-08 08:16:31 · For reference only, not investment advice and not tailored to your situation.